TerrAscend Corp.

TSND

CA88105E1088

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
2.27 ^CAD	-1.73%		-5.42%	+3.18%

05-09	Transcript : TerrAscend Corp., Q1 2024 Earnings Call, May 09, 2024
05-09	Earnings Flash (TSND) TERRASCEND Posts Q1 Revenue $80.6M	MT

TerrAscend Corp. acquired Four high-performing retail dispensaries in Maryland for $0.01 million.

November 08, 2023

TerrAscend Corp. (TSX:TSND) acquired Four high-performing retail dispensaries in Maryland for $0.01 million on September 30, 2023

TerrAscend Corp. (TSX:TSND) completed the acquisition of Four high-performing retail dispensaries in Maryland on September 30, 2023

Latest news about TerrAscend Corp.

Transcript : TerrAscend Corp., Q1 2024 Earnings Call, May 09, 2024	05-09
Earnings Flash (TSND) TERRASCEND Posts Q1 Revenue $80.6M	05-09	MT
TerrAscend Brief: Q1 Net Revenue of US$80.6 million, an increase of 16.1% year-over-year; Cash Flow from operations of $13.3 million and Free Cash Flow of $10.5 million in the quarter	05-09	MT
TerrAscend Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New Jersey	04-24	CI
Transcript : TerrAscend Corp., 2023 Earnings Call, Mar 14, 2024	03-14
TerrAscend Fourth-Quarter Loss Widens as Sales Rise by 26%	03-14	MT
TerrAscend Brief: Q4 Net loss from continuing operations US$41.8 Million	03-14	MT
TerrAscend Brief: Q4 Net Revenue was US$86.6 million, an increase of 25.5% year-over-year	03-14	MT
TerrAscend Corp. Reports Impairment Charges for the Three Months Ended December 31, 2023	03-14	CI
TerrAscend Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
North American Morning Briefing : Stock Futures Rise Ahead of PPI Data	03-14	DJ
TerrAscend Announcing Expansion of its Valhalla Product Offering	01-24	MT
TerrAscend Brief: Announcing expansion of its Valhalla product offering	01-24	MT
TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone State	01-24	CI
Transcript : TerrAscend Corp., Q3 2023 Earnings Call, Nov 09, 2023	11-09
TerrAscend Corp. Raises Earnings Guidance for 2023	11-09	CI
Earnings Flash (TSND) TERRASCEND Reports Q3 Net Revenue $89.2M	11-09	MT
Earnings Flash (TSND) TERRASCEND Posts Q3 Revenue $89.2M	11-09	MT
TerrAscend Brief: Raising Full Year 2023 Guidance	11-09	MT
TerrAscend Brief: Q3 Net Revenue of US$89.2 million, an increase of 34.7% year-over-year and 23.7% sequentially	11-09	MT
TerrAscend Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
North American Morning Briefing : Traders Await -2-	11-09	DJ
TerrAscend Corp. acquired Four high-performing retail dispensaries in Maryland for $0.01 million.	11-08	CI
TerrAscend Seeks Acquisitions	13/10/23	CI

Chart TerrAscend Corp.

Duration

Period

More charts

Company Profile

TerrAscend Corp. is a Canada-based cannabis company. The Company provides cannabis products, brands, and services to the United States and Canadian cannabinoid markets. It operates in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. (TerrAscend Growth) and retail operations in Canada. The Company operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. It also operates Peninsula Alternative Health, a medical dispensary in Maryland. The Company owns or licenses several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. Ilera Healthcare is a medical cannabis cultivator, processor and dispenser with operations in New Jersey. Valhalla Confections is a manufacturer of cannabis-infused edibles.

Sector

Drug Retailers

Calendar

17/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for TerrAscend Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.662 USD

Average target price

3.089 USD

Spread / Average Target

+85.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cannabis Product Retailers

	1st Jan change	Capi.
TERRASCEND CORP.	+3.18%	484M
GREEN THUMB INDUSTRIES INC.	+17.55%	3.03B
VERANO HOLDINGS CORP.	+15.99%	1.72B
GLASS HOUSE BRANDS INC.	+100.85%	681M
HIGH TIDE INC.	+45.54%	180M
MARIMED INC.	-4.48%	99.66M
CANTOURAGE GROUP SE	+0.97%	97.37M
GOLD FLORA CORPORATION	+56.25%	71.9M
NOVA CANNABIS INC.	+44.94%	54.13M

Cannabis Product Retailers

TerrAscend Corp.

Equities

TSND

CA88105E1088

Drug Retailers

TerrAscend Corp. acquired Four high-performing retail dispensaries in Maryland for $0.01 million.

EPS Revisions